Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic immunosuppression in marginal keratolysis.

D L Easty, P Madden, M I Jayson

    Transactions of the Ophthalmological Societies of the United Kingdom
    |September 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Higher rates of immune-related adverse events in circulating tumor DNA (ctDNA)-negative patients following adjuvant checkpoint inhibitor therapy.

    ESMO open·2026
    Same author

    Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Service evaluation of a new unscheduled paediatric dental service in Lothian, Scotland.

    International journal of paediatric dentistry·2023
    Same author

    Moving the Needle Toward Fair Compensation in Pediatric Nephrology.

    Frontiers in pediatrics·2022
    Same author

    Exploring the lived experience of women with rosacea: visible difference and psychological impact.

    The British journal of dermatology·2021
    Same author

    Stress response after race and endurance training sessions and competitions in Arabian horses.

    Preventive veterinary medicine·2021
    Same journal

    Brain stem and cerebellar deficits in eye movement control.

    Transactions of the ophthalmological societies of the United Kingdom·1986
    Same journal

    Strategies in Doppler ultrasound.

    Transactions of the ophthalmological societies of the United Kingdom·1986
    Same journal

    Congenital glaucoma--diagnosis and management.

    Transactions of the ophthalmological societies of the United Kingdom·1986
    Same journal

    Prostaglandins and other eicosanoids: their ocular transport, pharmacokinetics, and therapeutic effects.

    Transactions of the ophthalmological societies of the United Kingdom·1986
    Same journal

    Development of the ciliary body: a brief review.

    Transactions of the ophthalmological societies of the United Kingdom·1986
    Same journal

    Computer automated visual acuity testing for visual screening.

    Transactions of the ophthalmological societies of the United Kingdom·1986
    See all related articles

    Peripheral corneal melting syndrome can be challenging to treat. Short-term, non-corticosteroid immunosuppressive therapy may benefit severe cases unresponsive to other treatments.

    Area of Science:

    • Ophthalmology
    • Immunology

    Background:

    • Peripheral corneal melting syndrome (PCMS) is a severe ocular condition.
    • PCMS can lead to significant vision loss and requires effective treatment strategies.

    Purpose of the Study:

    • To describe the experience with eleven patients diagnosed with PCMS.
    • To evaluate the potential of non-corticosteroid immunosuppressive regimes in managing severe PCMS.

    Main Methods:

    • Retrospective review of eleven patients with PCMS.
    • Application of short-term, non-corticosteroid immunosuppressive treatments for severe, progressive disease.

    Main Results:

    • Eleven patients with PCMS were investigated and treated.
    • The study suggests that non-corticosteroid immunosuppressive regimes are a viable option for severe PCMS.

    Related Experiment Videos

    Conclusions:

    • Short-term non-corticosteroid immunosuppressive therapy should be considered for severe, progressive PCMS.
    • This treatment approach may be effective in cases refractory to other therapies.